Filtros de búsqueda

Lista de obras de Parameswaran Venugopal

A case of lenalidomide-dependent myelodysplastic syndrome

scientific article published on 30 June 2017

A novel method for single cell detection of in situ telomerase or histone H3 in combination with clonal analysis by FISH

artículo científico publicado en 2003

Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients

artículo científico publicado en 2012

All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.

artículo científico

Alterations in IRF1/IRF2 expression in acute myelogenous leukemia

artículo científico publicado en 2001

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.

artículo científico publicado en 2004

Biologic characteristics of patients with hypocellular myelodysplastic syndromes

artículo científico publicado en 1999

Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine

artículo científico publicado en 2012

Clofarabine: a new treatment option for patients with acute myeloid leukemia.

artículo científico publicado en 2009

Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes

artículo científico publicado en 1999

Cytokine gene activity in AML cells in vivo in patients

artículo científico publicado en 1998

Cytokine production by in vitro processed and unprocessed haematopoietic cells

artículo científico publicado en 2000

Cytokines, molecular biological abnormalities, and acute myelogenous leukemia

artículo científico publicado en 1997

Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia

artículo científico publicado en 2000

Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients

artículo científico publicado en 2010

Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

artículo científico publicado en 2007

Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes

artículo científico publicado en 1999

GM-CSF plus rituximab immunotherapy: translation of biologic mechanisms into therapy for indolent B-cell lymphomas.

artículo científico publicado en 2008

Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle ce

artículo científico publicado en 2011

Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia

artículo científico publicado en 2015

Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes.

artículo científico publicado en 2003

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.

artículo científico publicado en 1996

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

artículo científico publicado en 2012

P15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients

scientific article published on 01 October 2001

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

artículo científico publicado en 2015

Poor prognosis acute myelogenous leukemia 2--biological and molecular biological characteristics and treatment outcome

artículo científico publicado en 2000

Poor prognosis acute myelogenous leukemia: 1 – response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine)

article

Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapy

artículo científico publicado en 2001

Presence of activation-related m-RNA for EBV and CMV in the bone marrow of patients with myelodysplastic syndromes

scientific article published on 01 March 2001

Remicade as TNF suppressor in patients with myelodysplastic syndromes.

artículo científico publicado en 2004

SCF, IL-1beta, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients

artículo científico publicado en 2000

Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma

scientific article published on 22 June 2011

Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1

scientific article published on 01 May 2000

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.

artículo científico publicado en 2001

The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes.

artículo científico publicado en 2001

The evolving role of alemtuzumab in management of patients with CLL.

artículo científico publicado en 2005

Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: a new role for TNF alpha?

artículo científico publicado en 2000

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda